Celularity Inc. (NASDAQ:CELUW – Get Free Report) was the target of a significant increase in short interest in July. As of July 15th, there was short interest totaling 106,447 shares, an increase of 89.3% from the June 30th total of 56,239 shares. Based on an average daily volume of 165,384 shares, the days-to-cover ratio is currently 0.6 days.
Celularity Stock Performance
Shares of CELUW opened at $0.00 on Thursday. Celularity has a 12 month low of $0.00 and a 12 month high of $0.06.
About Celularity
Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.
The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.
Featured Stories
- Five stocks we like better than Celularity
- UnitedHealth Just Gave Wall Street a Clearer Turnaround Signal
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
Receive News & Ratings for Celularity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celularity and related companies with MarketBeat.com's FREE daily email newsletter.
